Physician profile
Paul E Bower
NPI 1144540386
$3,115.54
in general payments reported to CMS, 2019-2025
30 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $66.96 · 2021: $40.36 · 2022: $260 · 2023: $622 · 2024: $1,072 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $501.78 | 2019-2025 | Aquabeam System, Aquabeam Robotic System |
| Medtronic, INC. | $482.84 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $335.18 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Lithovue |
| Coloplast Corp | $282.00 | 2022-2025 | Speedicath |
| Abbvie INC. | $184.79 | 2024-2025 | |
| Neotract INC. | $149.26 | 2019-2020 | |
| Olympus America INC. | $119.56 | 2022-2025 | Itind System, Bovie |
| Myriad Genetic Laboratories, INC. | $107.08 | 2024 | Prolaris |
| Janssen Biotech, INC. | $78.91 | 2025 | Erleada |
| Teleflex LLC | $78.06 | 2024-2025 | Urolift, Barrigel |
| Tolmar, INC. | $76.62 | 2024-2025 | Jatenzo, Eligard |
| Pfizer INC. | $71.34 | 2025 | |
| Dendreon Pharmaceuticals LLC | $71.23 | 2025 | Provenge |
| Urogen Pharma, INC. | $61.79 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $58.15 | 2024-2025 | Keytruda, Welireg |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $52.82 | 2023-2025 | Flowstar |
| Axonics, INC. | $49.94 | 2023-2024 | Axonics |
| Astellas Pharma US INC | $48.38 | 2024-2025 | Xtandi |
| Intuitive Surgical, INC. | $44.39 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $41.32 | 2022 | |
| Becton, Dickinson and Company | $33.63 | 2023 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Convatec INC. | $29.17 | 2025 | |
| Alnylam Pharmaceuticals INC. | $27.51 | 2024 | Oxlumo |
| C. R. Bard, INC. & Subsidiaries | $25.10 | 2024 | Bard Urinary Drainage Bag |
| Accord Healthcare, INC. | $24.00 | 2024 | |
| Valencia Technologies Corporation | $20.38 | 2025 | Ecoin Device Kit |
| Halozyme INC | $17.99 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.58 | 2025 | Exparel |
| Ferring Pharmaceuticals INC. | $13.96 | 2025 | Adstiladrin |
| Pharmaand Gmbh | $12.78 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.